Who is the CEO of Madrigal Pharmaceuticals, Inc.?

The CEO of Madrigal Pharmaceuticals, Inc. is William J. Sibold.

What industry does Madrigal Pharmaceuticals, Inc. belong to?

Madrigal Pharmaceuticals, Inc. operates in the Biotechnology industry within the Healthcare sector.

Where is Madrigal Pharmaceuticals, Inc. headquartered?

Madrigal Pharmaceuticals, Inc. is headquartered at Four Tower Bridge, West Conshohocken, PA, 19428, US.

What is the IPO date of Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. went public on February 6, 2007.

How many employees does Madrigal Pharmaceuticals, Inc. have?

Madrigal Pharmaceuticals, Inc. has approximately 528 full-time employees.

Madrigal Pharmaceuticals, Inc.

MDGL•NASDAQ

Healthcare

Biotechnology

$298.40

$-0.77(-0.26%)

Madrigal Pharmaceuticals, Inc. (MDGL) Company Profile & Overview

Explore Madrigal Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Madrigal Pharmaceuticals, Inc. (MDGL) Company Profile & Overview

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

SectorHealthcare

IndustryBiotechnology

CEOWilliam J. Sibold

Contact Information

https://www.madrigalpharma.com

267 824 2827

Four Tower Bridge, West Conshohocken, PA, 19428

Company Facts

528 Employees

IPO DateFeb 6, 2007

CountryUS

Actively Trading

Frequently Asked Questions

;